Rezolute (RZLT) EBIT (2012 - 2026)
Rezolute (RZLT) reported EBIT of -$17.4 million for Q1 2026, up 13.27% on a YoY basis from -$15.3 million in Q1 2025, and up 28.3% sequentially from -$24.2 million in Q4 2025.
Rezolute (RZLT) EBIT (2012 - 2026) Analysis & Trends
Rezolute (RZLT) has 15 years of EBIT data on file, last reported at -$17.4 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 13.27% year-over-year to -$17.4 million; the trailing twelve-month figure through Mar 2026 stood at -$87.3 million (down 13.1% YoY), and the FY2025 full-year result was -$79.9 million, down 13.45% from the prior year.
- EBIT advanced to -$17.4 million in Q1 2026, from -$24.2 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$10.2 million in Q3 2022 to a low of -$25.8 million in Q2 2025.
- A 5-year average of -$17.0 million and a median of -$16.9 million in 2024 frame the typical range for EBIT.
- Across the five-year window, EBIT slumped 96.13% in 2022 and gained 13.27% in 2026, its largest moves.
- Tracing RZLT's EBIT over 5 years: stood at -$14.4 million in 2022, then decreased by 5.57% to -$15.2 million in 2023, then retreated by 12.41% to -$17.1 million in 2024, then slumped by 41.81% to -$24.2 million in 2025, then advanced by 28.3% to -$17.4 million in 2026.
- Business Quant data shows RZLT's EBIT at -$17.4 million in Q1 2026, -$24.2 million in Q4 2025, and -$19.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - | -17.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.37 Mn |
| Dec 31, 2025 | -24.22 Mn |
| Sep 30, 2025 | -19.82 Mn |
| Jun 30, 2025 | -25.85 Mn |
| Mar 31, 2025 | -20.02 Mn |
| Dec 31, 2024 | -17.08 Mn |
| Sep 30, 2024 | -16.94 Mn |
| Jun 30, 2024 | -23.10 Mn |
| Mar 31, 2024 | -16.21 Mn |
| Dec 31, 2023 | -15.19 Mn |
| Sep 30, 2023 | -15.91 Mn |
| Jun 30, 2023 | -14.24 Mn |
| Mar 31, 2023 | -17.14 Mn |
| Dec 31, 2022 | -14.39 Mn |
| Sep 30, 2022 | -10.22 Mn |
| Jun 30, 2022 | -11.30 Mn |
| Mar 31, 2022 | -10.75 Mn |
| Dec 31, 2021 | -12.15 Mn |
| Sep 30, 2021 | -7.64 Mn |
| Jun 30, 2021 | -6.64 Mn |